Minerva Neurosciences, Inc. Stockholders Equity

Quick Answer

Minerva Neurosciences, Inc. reported Stockholders Equity of -$140.75 million for the year ending 2025.

  • Minerva Neurosciences, Inc. showed a decrease of -447.8% in Stockholders Equity from 2024 to 2025.
  • This data is from Minerva Neurosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2015: $74.44 million | Q2 2015: $68.38 million | Q3 2015: $63.07 million | Q1 2016: $66.65 million | Q2 2016: $120.61 million | Q3 2016: $113.14 million | Q1 2017: $106.29 million | Q2 2017: $98.03 million | Q3 2017: $130.18 million | Q1 2018: $121.29 million | Q2 2018: $110.66 million | Q3 2018: $101.39 million | Q1 2019: $77.42 million | Q2 2019: $67.27 million | Q3 2019: $55.53 million | Q1 2020: $18.62 million | Q2 2020: $56.94 million | Q3 2020: $58.02 million | Q1 2021: $45.37 million | Q2 2021: $36.17 million | Q3 2021: $28.08 million | Q1 2022: -$736.1 thousand | Q2 2022: -$8.38 million | Q3 2022: -$14.25 million | Q1 2023: -$26.62 million | Q2 2023: -$12.51 million | Q3 2023: -$20.05 million | Q1 2024: -$36.59 million | Q2 2024: -$44.49 million | Q3 2024: -$21.67 million | Q1 2025: -$29.15 million | Q2 2025: -$32.11 million | Q3 2025: -$34.58 million.
  • Over the full 14 years of available data (2012 to 2025), Minerva Neurosciences, Inc.'s Stockholders Equity has declined by 740,139.3%.
  • Historical annual values: Fiscal year 2025: -$140.75 million | Fiscal year 2024: -$25.69 million | Fiscal year 2023: -$28.46 million | Fiscal year 2022: -$20.02 million | Fiscal year 2021: $7.98 million | Fiscal year 2020: $52.66 million | Fiscal year 2019: $27.78 million | Fiscal year 2018: $90.26 million | Fiscal year 2017: $131.60 million | Fiscal year 2016: $105.98 million | Fiscal year 2015: $55.32 million | Fiscal year 2014: $51.50 million | Fiscal year 2013: $20.18 million | Fiscal year 2012: $19.0 thousand.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: